Putnam VT Global Health Care Fund
Putnam VT Global Health Care Fund reported 49 holdings worth US$148M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 27, 2026
Putnam VT Global Health Care Fund reported 49 holdings worth US$148M as of Jun 30, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. Filed Aug 27, 2026 (Form N-PORT).
- Holdings
- 49
- Value as reported
- US$148M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 16,800 | US$20.2M | 13.6% |
| Johnson & Johnson | 53,032 | US$13.5M | 9.1% |
| Unitedhealth Group Incorporated | 25,740 | US$10.7M | 7.2% |
| Abbvie Inc. | 39,100 | US$9.84M | 6.6% |
| Merck & Company, Inc. | 63,646 | US$8.18M | 5.5% |
| Novartis Ag | 48,184 | US$7.53M | 5.1% |
| Astrazeneca Plc | 35,532 | US$6.63M | 4.5% |
| Intuitive Surgical, Inc. | 13,360 | US$5.31M | 3.6% |
| Thermo Fisher Scientific Inc | 9,840 | US$4.93M | 3.3% |
| Cvs Health Corporation | 42,400 | US$4.39M | 3.0% |
| Gilead Sciences, Inc. | 33,800 | US$4.27M | 2.9% |
| Edwards Lifesciences Corporation | 45,800 | US$4.14M | 2.8% |
| Vertex Pharmaceuticals Incorporated | 7,760 | US$3.85M | 2.6% |
| Roche Holding Ltd | 9,330 | US$3.84M | 2.6% |
| Cardinal Health, Inc. | 15,100 | US$3.59M | 2.4% |
| Gsk Plc | 128K | US$3.37M | 2.3% |
| Mckesson Corporation | 4,060 | US$3.07M | 2.1% |
| Elevance Health, Inc. | 7,560 | US$2.92M | 2.0% |
| Waters Corporation | 5,680 | US$2.13M | 1.4% |
| Dexcom, Inc. | 30,800 | US$2.07M | 1.4% |
| Novo Nordisk A/s Class B | 42,400 | US$2.04M | 1.4% |
| Hoya Corporation | 12,600 | US$2.03M | 1.4% |
| Sanofi Sa | 19,883 | US$1.7M | 1.1% |
| Amgen Inc. | 4,560 | US$1.65M | 1.1% |
| Argenx Se | 1,445 | US$1.45M | 0.98% |
| Bristol-myers Squibb Company | 24,500 | US$1.41M | 0.95% |
| Royalty Pharma Plc | 21,400 | US$1.2M | 0.81% |
| Apogee Therapeutics, Inc. | 8,500 | US$1.13M | 0.76% |
| Chugai Pharmaceutical Co., Ltd. | 23,700 | US$1.09M | 0.74% |
| Insmed Incorporated | 8,600 | US$917K | 0.62% |
| Ligand Pharmaceuticals Incorporated | 2,700 | US$853K | 0.58% |
| Pacs Group, Inc. | 20,000 | US$853K | 0.57% |
| Celcuity Inc. | 8,000 | US$837K | 0.56% |
| United Therapeutics Corporation | 1,520 | US$824K | 0.56% |
| Rhythm Pharmaceuticals, Inc. | 7,400 | US$822K | 0.55% |
| Ascendis Pharma A/s | 3,064 | US$817K | 0.55% |
| Xenon Pharmaceuticals Inc. | 13,000 | US$785K | 0.53% |
| Protagonist Therapeutics, Inc. | 6,300 | US$772K | 0.52% |
| Cytokinetics, Incorporated | 5,200 | US$443K | 0.30% |
| Newamsterdam Pharma Company N.v. | 11,600 | US$393K | 0.27% |
| Boston Scientific Corporation | 0 | US$0 | 0.00% |
| Iqvia Holdings, Inc. | 0 | US$0 | 0.00% |
| Revolution Medicines, Inc. | 0 | US$0 | 0.00% |
| Ucb S.a. | 0 | US$0 | 0.00% |
| Hca Healthcare, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Regeneron Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Medtronic Plc. | 0 | US$0 | 0.00% |
| Precigen, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related